Ledger.Open graph →
SEC Form D · filed December 20, 2019

ENDRA Life Sciences Inc

Offering
$8.6M
Sold
$8.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ANN ARBOR, MI
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Alexander S. Tokman · Ann Arbor, MIDirectorMichael S. Harsh · Ann Arbor, MIDirectorAnthony R. Digiandomenico · Ann Arbor, MIDirectorSanjiv S. Gambhir · Ann Arbor, MIDirectorDavid R. Wells · Ann Arbor, MIExecMichael R. Thornton · Ann Arbor, MIExecFrancois R. Michelon · Ann Arbor, MIExec · DirectorAndrew Zbella · New York, NYExecRafi Syed · San Carlos, CADirectorEugene Lee · San Carlos, CAExecJohn Fay · New York, NYExec · DirectorTheodore Blosser · San Carlos, CADirectorAlexander Y. Tokman · Ann Arbor, MIDirectorArshdeep Mand · San Carlos, CADirectorAndrew Adams · Atlanta, GADirectorRobert G. Bearden, Jr · Atlanta, GADirectorRebecca Parekh · New York, NYDirectorSarrah Hallock · New York, NYDirectorKane Sarhan · New York, NYExecLiza Landsman · New York, NYExecAnne-Cecile Vasseur-Jourdren · Luxembourg-Findel, LuxembourgExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗